Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Delgado

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Toxics|March 26, 2025
Arsenic Exposure During Pregnancy and Childhood: Factors Explaining Changes over a DecadePaola Rubilar, Macarena Hirmas-Adauy, Mauricio Apablaza, et al.
Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia|December 21, 2019
[Sociodemographic risk factors of hantavirus cardiopulmonary syndrome]Cecilia Vial C, Francisca Valdivieso R, Analía Cuiza V, et al.
Antiviral Therapy|October 16, 2014
A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virusPablo A Vial, Francisca Valdivieso, Mario Calvo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Genetic risk factors for Mesoamerican nephropathyDavid J Friedman, Dominick A Leone, Juan José Amador, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Toxics|March 26, 2025
Arsenic Exposure During Pregnancy and Childhood: Factors Explaining Changes over a DecadePaola Rubilar, Macarena Hirmas-Adauy, Mauricio Apablaza, et al.
Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia|December 21, 2019
[Sociodemographic risk factors of hantavirus cardiopulmonary syndrome]Cecilia Vial C, Francisca Valdivieso R, Analía Cuiza V, et al.
Antiviral Therapy|October 16, 2014
A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virusPablo A Vial, Francisca Valdivieso, Mario Calvo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Genetic risk factors for Mesoamerican nephropathyDavid J Friedman, Dominick A Leone, Juan José Amador, et al.
Pageof 8